Event coordinated by the Hepatitis B Foundation

2026 Schedule

2027 Program Schedule Coming Soon!

08:00-12:45

Level 2

Emerging Researchers’ Workshop

(registration required)

08:00 – 08:30

Registration & Networking & High Tea Breakfast

08:00 – 08:40

Welcome & Introductions
Chari Cohen, Thomas Tu & Nina Le Bert

08:40 – 09:10

Icebreaker Activity

09:10 – 10:30

Panel & Audience Discussion on “Navigating Transition Phases in Your Research Career”
Moderator: Jochen Wettengel
Panel: Haitao Guo, Rachel Jeng, Wenhui Li, Lefteris Michailidis, Alexander Ploss, Ulrike Protzer

10:30-10:45

Break

10:45 – 12:00

Table Discussions
Table Discussions: Peer-to-peer discussion of topics related to transition phases in research careers
12:00 – 12:45

Level 2

Lunch & Networking with Panelists and Peers (Level 2)

13:00 – 14:30

Levels 4 & 5

Hepatitis B Community Forum

13:00-13:05

Welcome and Opening Remarks
Chari Cohen, DrPH, MPH

13:05 – 13:25

Epidemiology, Progress and Challenges with Hepatitis B Elimination in Southeast Asia
Seng Gee Lim, FRACP, FRCP, FAMS, MD

13:25 – 13:45

Progress towards Hepatitis B Elimination in Vietnam
Doan Dao, MD

13:45 – 14:15

Lived experience of hepatitis B or D in Asia – Panel Discussion
Panelists: Chris, Dee, Lien and Tay

14:15 – 14:25

Q&A
Moderated by Catherine Freelan

14:25 – 14:30

Closing Remarks
Maura Dandri, MD, PhD
14:30 – 15:00

Level 4&5

High Tea for Community Forum & ICE-HBV Symposium

15:00 – 18:00

Levels 4 & 5

ICE-HBV Symposium: Therapeutic Vaccines for Chronic Hepatitis B: Optimizing Their Utility in Novel Therapeutic Combinations

(registration required)

15:00 – 15:10

Welcome and Opening Remarks
Adam J Gehring & Anna D. Kosinska

15:10 – 15:35

What we’ve learned, current strategies and future prospects for therapeutic vaccines
Speaker: Anna Kosinska

15:35 – 16:00

Vaccine combinations in the current landscape of novel HBV therapies
Speaker: Seng Gee Lim

16:00 – 16:25

What deep translational studies teach us about vaccine efficacy in combination therapies, experience from the Brii studies
Speaker: Antonio Bertoletti

16:25 – 16:45

Coffee and Tea Break (Level 4 + 5)

16:45 – 17:05

How much would effective therapeutic vaccination improve functional cure rates?
Speaker: Adam Gehring

17:05-17:15

TherVacB – on the way to the clinic
Speaker: Ulrike Protzer

17:15-17:25

Immunogenicity and antiviral efficacy of GS-2829 and GS-6779 in CHB patients with a broad range of baseline HBsAg levels
Speaker: Simon Fletcher

17:25-17:35

Immunogenicity and long-term antiviral effect of VRON-0200
Speaker: Sue Currie

17:35 – 18:00

Round Table Discussion & Closing of ICE-HBV Symposium

18:00 – 20:00

Level 2

Welcome Reception: Refreshing Drinks & Asian Live Food Stations

08:30 – 09:00

Levels 4 & 5

Morning Coffee & Networking

9:00 – 9:30

Levels 4 & 5

Lion Dance & Welcome Address (Level 4 + 5)

Thomas Tu, Associate Professor, Westmead Clinical School, University of Sydney, Australia & Nina Le Bert, Assistant Professor, Duke-NUS Medical School, Singapore

10:30 - 11:00

Levels 4 & 5

Morning Coffee & Networking

11:00 – 12:30

Levels 4 & 5

Session 1: New Models (Level 4 + 5)

Session Chairs: Robert Schwartz & Helene Strick-Marchand

11:00 – 11:12

Establishment of an immunocompetent mouse model of hepadnavirus infection using Asian grey shrew hepatitis B virus – Chen Li

11:12 – 11:17

Q&A

11:17 – 11:29

A late entry step restricts hepatitis B virus infection in murine hepatocytes
Xupeng Hong

11:29 – 11:34

Q&A

11:34 – 11:46

Oncostatin M and forskolin confer permissiveness to HBV infection in A549-NTCP lung carcinoma cells
Yi Ni

11:46 – 11:51

Q&A

11:51 – 12:03

A rice rat hepadnavirus efficiently replicates and forms cccDNA in cotton rat and mouse hepatocytes
Qingyan Wu

11:46 – 11:51

Q&A

12:08 – 12:20

Modeling hepatitis B driven hepatocarcinogenesis in zebrafish
Samer Ayoub

12:20-12:25

Q&A

12:30 – 12:45

Levels 4 & 5

Sponsors & Travel Awards

12:45 – 14:00

Levels 2 & 4

Buffet Lunch & Networking

14:00- 14:40

Levels 4 & 5

Keynote Lecture 1

14:00 – 14:30

“Cancer-causing viruses in cats (and how they will save the world)”
Speaker: Julia Beatty

14:30 – 14:40

Q&A

14:40 – 15:30

Levels 4 & 5

Grand Discussion Round 1 - Animal models of Hepatitis B: what we have, how they can inform us, and where we need to go from here

Panelists: Ulrike Protzer, Luca Guidotti, Maura Dandri, Carla Coffin, Ben Burowitz, Julia Beatty; Moderator: Thomas Tu

15:30 – 16:00

Levels 4 & 5

Afternoon Coffee & Networking

16:00 – 17:45

Levels 4 & 5

Session 2: HBV Pathogenesis

Session Chairs: Adam Gehring & Margaret Littlejohn

16:00 – 16:12

Spatial profiling the chronic hepatitis B liver identifies viralimmune niches that perturb local immune responses in a zonal dependent manner
James Harris

16:12 – 16:17

Q&A

16:17 – 16:29

Visualizing the spatial dynamics of in situ HBV-specific tissueresident memory T cells and hepatic immune niches that govern tumor control in hepatocellular carcinoma
Jing-Yun Wu

16:29 – 16:34

Q&A

16:34 – 16:46

Kupffer cells modulate the early host immune response and severity of hepatitis in the woodchuck infection model of hepatitis B Md
Deen Islam

16:46 – 16:51

Q&A

16:51 – 17:03

Hepatic Tertiary Lymphoid Structures Enable Local Adaptive Immune Responses in the HBV-Replicating Liver
Cristian G Beccaria

17:03 – 17:08

Q&A

17:08 – 17:20

Proliferation of hepatocytes in postnatal period depletes nuclear cccDNA in vivo
Qiong Li

17:20 – 17:25

Q&A

17:25 – 17:37

Visualization of HBV by Metabolic Glycan Labeling
Yi Wang

17:37 – 17:42

Q&A

17:30 – 19:00

Level 2

Poster Session 1

High Tea & Drinks

14:40 – 15:30

Levels 4 & 5

Emerging Researcher’s Dinner

By Invitation Only RSVP Required

08:30 – 09:00

Levels 4 & 5

Morning Coffee & Networking

09:00 – 10:30

Levels 4 & 5

Session 3: Novel Antivirals & Immunotherapies

Session Chairs: Carla Coffin & Koichi Watashi

Lectures relating to Novel Antivirals & Immunotherapies with Q & A following each presentation.

10:30 – 11:00

Levels 4 & 5

Morning Coffee & Networking

11:00 – 12:30

Levels 4 & 5

Session 4: Novel Immunotherapies & Mechanisms

Session Chairs: Upkar Gill & Anna Kosinska

Lectures relating to Novel Immunotherapies & Mechanisms with Q & A following each presentation.

12:30 – 13:30

Levels 2 & 4

Buffet Lunch & Networking

13:30 – 14:00

Levels 4 & 5

Parexel, HBF and ICE-HBV Symposium: Thought leadership: Building the Future of Hepatitis B Clinical Development Together (Level 4 + 5)

Moderator: Anne Kasmar
Panelists: Emerging researchers alongside leaders from ICE-HBV and HBF
14: 00 – 15:30

Levels 4 & 5

Session 5: cccDNA & Viral Persistence

Session Chairs: Lena Allweiss & Haitao Guo

Lectures relating to cccDNA & Viral Persistence with Q & A following each presentation.

15:30 – 16:00

Levels 4 & 5

Afternoon Coffee & Networking

16:00 – 17:30

Levels 4 & 5

Session 6: HBV Integration

Session Chairs: Chloe Thio & Teresa Pollicino

Lectures about HBV Integration with Q & A following each presentation.

17:30 – 19:00

Level 2

Poster Session 2

High Tea & Drinks

08:30 – 09:00

Levels 4 & 5

Morning Coffee & Networking

09:00 – 10:30

Levels 4 & 5

Session 7: HDV Pathogenesis & Therapy

Session Chairs: Gnimah Eva Gnouamozi & Tassilo Volz

Lectures relating to HDV Pathogenesis & Therapy with Q & A following each presentation.

10:30 – 11:00

Levels 4 & 5

Morning Coffee & Networking

11:00 – 12:30

Levels 4 & 5

Session 8: Intrahepatic & Peripheral HBV-specific T cells

Session Chairs: Carolina Boni & Yang Cheng

Lectures relating to Intrahepatic & Peripheral HBV-specific T cells with Q & A following each presentation.

12:30 – 13:30

Levels 2 & 4

Buffet Lunch & Networking

13:30 – 14:10

Levels 4 & 5

Keynote Lecture 2

“The immunological and structural basis of hepatotropic viral adaptation”
Speaker: Arash Grakoui, Emory University

Q&A following the lecture

 

14:10 – 15:00

Levels 4 & 5

Grand Discussion Round 2 - Immune recovery in chronic HBV: does it really mimic acute resolved HBV infection?

Panelists: Georg Lauer, M

15:00 – 15:30

Levels 4 & 5

Afternoon Coffee & Networking

15:30 – 17:00

Levels 4 & 5

Session 9: HBV-specific Humoral Immunity (Level 4 + 5)

Session Chairs: Valeria Fumagalli & Loghman Salimzadeh

Lectures about HBV-specific Humoral Immunity with Q & A following each presentation.
17:30 – 18:00

Limited shuttle buses to Sentosa Island from selected hotels + CHI

18:00 – 22:30

Sunset Beach Party & Gala Dinner - ticketed event

Tanjong Beach Club – Sentosa Island

08:30 – 09:00

Levels 4 & 5

Morning Coffee & Networking

09:00 – 10:30

Levels 4 & 5

Session 10: Viral Replication

Session Chairs: Jianming Hu & Christine Neuveut

Lectures relating to Viral Replication with Q & A following each presentation.
10:30 – 11:00

Levels 4 & 5

Morning Coffee & Networking

11:00 – 12:30

Levels 4 & 5

Session 11: Host-Viral Interactions

Session Chairs: Barbara Testoni & Chunkyu Ko

Lectures relating to Host-Viral Interactions with Q & A following each presentation.

12:30 – 12:45

Levels 2 & 4

Farewell + Awards + HBV 2027

12:45 – 14:00

Levels 4 & 5

High Tea Buffet

12:45 – 14:30

Level 2

High Tea Buffet & HBV Organizers Meeting

by invitation only (Level 2)